Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel

Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel

Background and Aim. The availability of new treatments for metastatic castrate-resistant prostate cancer (mCRPC) patients increases the need for reliable biomarkers to help clinicians to choose the better sequence strategy. The aim of the present retrospective and observational work is to investigat...

Full description

Bibliographic Details
Main Authors: E. Quaquarini, D. D’Ambrosio, F. Sottotetti, F. Gallivanone, M. Hodolic, P. Baiardi, R. Palumbo, C. Vellani, C. Canevari, A. Bernardo, I. Castiglioni, C. Porta, G. Trifirò
Format: Article
Language:English
Published: Hindawi-Wiley 2019-01-01
Series:Contrast Media & Molecular Imaging
Online Access:http://dx.doi.org/10.1155/2019/4325946

Internet

http://dx.doi.org/10.1155/2019/4325946

Similar Items